204 related articles for article (PubMed ID: 27571786)
21. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.
Worodria W; Menten J; Massinga-Loembe M; Mazakpwe D; Bagenda D; Koole O; Mayanja-Kizza H; Kestens L; Mugerwa R; Reiss P; Colebunders R;
Antivir Ther; 2012; 17(5):841-8. PubMed ID: 22543224
[TBL] [Abstract][Full Text] [Related]
22. A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition.
Sharma SK; Dhooria S; Barwad P; Kadhiravan T; Ranjan S; Miglani S; Gupta D
Indian J Med Res; 2010 Jun; 131():804-8. PubMed ID: 20571170
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Accuracy of the INSHI Consensus Case Definition for the Diagnosis of Paradoxical Tuberculosis-IRIS.
Stek C; Buyze J; Menten J; Schutz C; Thienemann F; Blumenthal L; Maartens G; Boyles T; Wilkinson RJ; Meintjes G; Lynen L
J Acquir Immune Defic Syndr; 2021 Apr; 86(5):587-592. PubMed ID: 33394813
[TBL] [Abstract][Full Text] [Related]
24. Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome.
Meintjes G; Skolimowska KH; Wilkinson KA; Matthews K; Tadokera R; Conesa-Botella A; Seldon R; Rangaka MX; Rebe K; Pepper DJ; Morroni C; Colebunders R; Maartens G; Wilkinson RJ
Am J Respir Crit Care Med; 2012 Aug; 186(4):369-77. PubMed ID: 22700860
[TBL] [Abstract][Full Text] [Related]
25. Prolonged tuberculosis-associated immune reconstitution inflammatory syndrome: characteristics and risk factors.
Bana TM; Lesosky M; Pepper DJ; van der Plas H; Schutz C; Goliath R; Morroni C; Mendelson M; Maartens G; Wilkinson RJ; Meintjes G
BMC Infect Dis; 2016 Sep; 16(1):518. PubMed ID: 27677424
[TBL] [Abstract][Full Text] [Related]
26. Tuberculosis associated immune reconstitution inflammatory syndrome in patients infected with HIV: meningitis a potentially life threatening manifestation.
Agarwal U; Kumar A; Behera D; French MA; Price P
AIDS Res Ther; 2012 May; 9(1):17. PubMed ID: 22620862
[TBL] [Abstract][Full Text] [Related]
27. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial.
Mfinanga SG; Kirenga BJ; Chanda DM; Mutayoba B; Mthiyane T; Yimer G; Ezechi O; Connolly C; Kapotwe V; Muwonge C; Massaga J; Sinkala E; Kohi W; Lyantumba L; Nyakoojo G; Luwaga H; Doulla B; Mzyece J; Kapata N; Vahedi M; Mwaba P; Egwaga S; Adatu F; Pym A; Joloba M; Rustomjee R; Zumla A; Onyebujoh P
Lancet Infect Dis; 2014 Jul; 14(7):563-71. PubMed ID: 24810491
[TBL] [Abstract][Full Text] [Related]
28. Frequency of CXCR3
Tibúrcio R; Narendran G; Barreto-Duarte B; Queiroz ATL; Araújo-Pereira M; Anbalagan S; Nayak K; Ravichandran N; Subramani R; Antonelli LRV; Satagopan K; Anbalagan K; Porter BO; Sher A; Swaminathan S; Sereti I; Andrade BB
Front Immunol; 2022; 13():873985. PubMed ID: 35432354
[TBL] [Abstract][Full Text] [Related]
29. Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV.
Narendran G; Kavitha D; Karunaianantham R; Gil-Santana L; Almeida-Junior JL; Reddy SD; Kumar MM; Hemalatha H; Jayanthi NN; Ravichandran N; Krishnaraja R; Prabhakar A; Manoharan T; Nithyananthan L; Arjunan G; Natrajan M; Swaminathan S; Andrade BB
PLoS One; 2016; 11(9):e0163298. PubMed ID: 27643598
[TBL] [Abstract][Full Text] [Related]
30. Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial.
Coelho LE; Chazallon C; Laureillard D; Escada R; N'takpe JB; Timana I; Messou E; Eholie S; Khosa C; Chau GD; Cardoso SW; Veloso VG; Delaugerre C; Molina JM; Grinsztejn B; Marcy O; De Castro N
Open Forum Infect Dis; 2024 Mar; 11(3):ofae035. PubMed ID: 38486816
[TBL] [Abstract][Full Text] [Related]
31. Paradoxical and Unmasking HIV Immune Reconstitution Inflammation Syndrome in Antiretroviral-Naïve Pregnant Women: A Prospective Cohort Study.
Muthuka JK; Nyamai EM; Oluoch K; Maibvise C; Nabaweesi R
Cureus; 2024 Jan; 16(1):e52989. PubMed ID: 38406047
[TBL] [Abstract][Full Text] [Related]
32. Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcome.
Bonnet M; Baudin E; Jani IV; Nunes E; Verhoustraten F; Calmy A; Bastos R; Bhatt NB; Michon C
PLoS One; 2013; 8(12):e84585. PubMed ID: 24367678
[TBL] [Abstract][Full Text] [Related]
33. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
[TBL] [Abstract][Full Text] [Related]
34. Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.
Tan HY; Yong YK; Andrade BB; Shankar EM; Ponnampalavanar S; Omar SF; Narendran G; Kamarulzaman A; Swaminathan S; Sereti I; Crowe SM; French MA
AIDS; 2015 Feb; 29(4):421-31. PubMed ID: 25565499
[TBL] [Abstract][Full Text] [Related]
35. Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome.
Haddow LJ; Moosa MY; Easterbrook PJ
AIDS; 2010 Jan; 24(1):103-8. PubMed ID: 19926965
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome.
Chakrabarti LA; Boucherie C; Bugault F; Cumont MC; Roussillon C; Breton G; Patey O; Chêne G; Richert L; Lortholary O;
AIDS; 2014 Jul; 28(11):1593-602. PubMed ID: 24865974
[TBL] [Abstract][Full Text] [Related]
37. Same-day versus rapid ART initiation in HIV-positive individuals presenting with symptoms of tuberculosis: Protocol for an open-label randomized non-inferiority trial in Lesotho and Malawi.
Gerber F; Semphere R; Lukau B; Mahlatsi P; Mtenga T; Lee T; Kohler M; Glass TR; Amstutz A; Molatelle M; MacPherson P; Marake NB; Nliwasa M; Ayakaka I; Burke R; Labhardt N
PLoS One; 2024; 19(2):e0288944. PubMed ID: 38330045
[TBL] [Abstract][Full Text] [Related]
38. Impact of immune reconstitution inflammatory syndrome on antiretroviral therapy adherence.
Nachega JB; Morroni C; Chaisson RE; Goliath R; Efron A; Ram M; Maartens G
Patient Prefer Adherence; 2012; 6():887-91. PubMed ID: 23271897
[TBL] [Abstract][Full Text] [Related]
39. Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome.
Conesa-Botella A; Meintjes G; Coussens AK; van der Plas H; Goliath R; Schutz C; Moreno-Reyes R; Mehta M; Martineau AR; Wilkinson RJ; Colebunders R; Wilkinson KA
Clin Infect Dis; 2012 Oct; 55(7):1004-11. PubMed ID: 22715179
[TBL] [Abstract][Full Text] [Related]
40. Tuberculosis (TB)-associated immune reconstitution inflammatory syndrome in TB-HIV co-infected patients in Malaysia: prevalence, risk factors, and treatment outcomes.
Tan HY; Yong YK; Lim SH; Ponnampalavanar S; Omar SF; Pang YK; Kamarulzaman A; Price P; Crowe SM; French MA
Sex Health; 2014 Dec; 11(6):532-9. PubMed ID: 25200957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
